Mend (Pharmaceuticals and Biotechnology)

New York, NY · Founded 2014 · Privately Held (backing)

Developer of clinical nutritional products designed to assist people in healing and living a quality life. Mend (Pharmaceuticals and Biotechnology) is based in New York, NY and was founded in 2014. Its last reported valuation was $115 million in Feb 2026. It has raised $36.2 million.

Last reported valuation
$115.0M
Oct 2026
Priced at
—
Total raised
$36.2M
Last round
—

Who backs Mend (Pharmaceuticals and Biotechnology)?

16 investors
InvestorType
Alumni VenturesVenture capital
S2G InvestmentsVenture capital
iSelect FundVenture capital
The Pay It Forward CompanyVenture capital
H/L VenturesVenture capital
Claridge Venture PartnersFamily office
Tech Council VenturesVenture capital
Sage Hill InvestorsFamily office
Volta CircleFamily office
GenHenn CapitalFamily office
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Mend (Pharmaceuticals and Biotechnology) investors

16 investors are on record for Mend (Pharmaceuticals and Biotechnology), including Alumni Ventures, S2G Investments, iSelect Fund and The Pay It Forward Company. By type, the record holds 6 venture capital firms and 4 family offices.

Free account
More of Mend (Pharmaceuticals and Biotechnology) with a free account
  • ·The complete investor list: 16 names
  • ·Watch Mend (Pharmaceuticals and Biotechnology): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Mend (Pharmaceuticals and Biotechnology). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View